George, Mark S <br/><br/>
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.  [electronic resource] 

 -  Schizophrenia research  Jul 2007 
 - 42-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0920-9964 
<br/><br/><label>Standard No.: </label>10.1016/j.schres.2007.03.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Brain--blood supply<br/>Cross-Over Studies<br/>Dopamine Agonists--adverse effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Injections, Subcutaneous<br/>Magnetic Resonance Imaging<br/>Male<br/>Memory, Short-Term--drug effects<br/>Middle Aged<br/>Neuropsychological Tests<br/>Oxygen--blood<br/>Phenanthridines--administration & dosage<br/>Pilot Projects<br/>Psychiatric Status Rating Scales<br/>Receptors, Dopamine D1--agonists<br/>Regional Blood Flow--drug effects<br/>Schizophrenia--diagnosis<br/>Treatment Outcome